Part 1
Part 2
Part 3
Part 5
Description
The global Aptamer-Drug Conjugates (ApDC) revenue was US$ 10.4 million in 2023 and is forecast to a readjusted size of US$ 24.3 million by 2030 with a CAGR of 13.1% during the review period (2024-2030). In United States the Aptamer-Drug Conjugates (ApDC) revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
Aptamer-Drug Conjugates (ApDC) Market Size
M= millions and B=billions
This report focuses on global and United States Aptamer-Drug Conjugates (ApDC) market, also covers the segmentation data of other regions in regional level and county level.
Aptamer-drug conjugates (ApDC) is a new form of drug that combines the specificity of nucleic acid aptamers and the therapeutic effect of drug molecules. ApDC connects nucleic acid aptamers and drug molecules through chemical linkers to form a complex with targeting and therapeutic effects.
The global key players of Aptamer-Drug Conjugates (ApDC) include Aptamer Sciences, Oligon, AptaBio Therapeutics, etc. The global five biggest players hold a share of % in 2023.
Global Aptamer-Drug Conjugates (ApDC) Scope and Market Size
Aptamer-Drug Conjugates (ApDC) market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Aptamer-Drug Conjugates (ApDC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Aptamer-Drug Conjugates (ApDC) market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
Market Segmentation
Report Metric
Details
Report Title
Global and United States Aptamer-Drug Conjugates (ApDC) Market Report & Forecast 2024-2030
Forecasted Market Size in 2030
US$ 24.3 million
CAGR(2024-2030)
13.1%
Market Size Available for Years
2019-2030
Global Aptamer-Drug Conjugates (ApDC) Companies Covered
Aptamer Sciences, Oligon, AptaBio Therapeutics
Global Aptamer-Drug Conjugates (ApDC) Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Aptamer-Drug Conjugates (ApDC) Market, Segment by Type
Covalent Coupling
Non-Covalent Coupling
Global Aptamer-Drug Conjugates (ApDC) Market, Segment by Application
Biopharmaceutical Company
Research Institute
Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces Aptamer-Drug Conjugates (ApDC) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Aptamer-Drug Conjugates (ApDC) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Aptamer-Drug Conjugates (ApDC) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aptamer-Drug Conjugates (ApDC) revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
Table of Contents
1 Study Coverage
1.1 Aptamer-Drug Conjugates (ApDC) Product Introduction
1.2 Global Aptamer-Drug Conjugates (ApDC) Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Aptamer-Drug Conjugates (ApDC) Market Size for the Year 2019-2030
1.2.2 United States Aptamer-Drug Conjugates (ApDC) Market Size for the Year 2019-2030
1.3 Aptamer-Drug Conjugates (ApDC) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Aptamer-Drug Conjugates (ApDC) in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Aptamer-Drug Conjugates (ApDC) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Aptamer-Drug Conjugates (ApDC) Market Dynamics
1.4.1 Aptamer-Drug Conjugates (ApDC) Industry Trends
1.4.2 Aptamer-Drug Conjugates (ApDC) Market Drivers
1.4.3 Aptamer-Drug Conjugates (ApDC) Market Challenges
1.4.4 Aptamer-Drug Conjugates (ApDC) Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Aptamer-Drug Conjugates (ApDC) by Type
2.1 Aptamer-Drug Conjugates (ApDC) Market by Type
2.1.1 Covalent Coupling
2.1.2 Non-Covalent Coupling
2.2 Global Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019, 2023 & 2030)
2.3 Global Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2030)
2.4 United States Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019, 2023 & 2030)
2.5 United States Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2030)
3 Aptamer-Drug Conjugates (ApDC) by Application
3.1 Aptamer-Drug Conjugates (ApDC) Market by Application
3.1.1 Biopharmaceutical Company
3.1.2 Research Institute
3.1.3 Other
3.2 Global Aptamer-Drug Conjugates (ApDC) Market Size, by Application (2019, 2023 & 2030)
3.3 Global Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2030)
3.4 United States Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019, 2023 & 2030)
3.5 United States Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2030)
4 Global Aptamer-Drug Conjugates (ApDC) Competitor Landscape by Company
4.1 Global Aptamer-Drug Conjugates (ApDC) Market Size by Company
4.1.1 Global Key Companies of Aptamer-Drug Conjugates (ApDC), Ranked by Revenue (2023)
4.1.2 Global Aptamer-Drug Conjugates (ApDC) Revenue by Player (2019-2024)
4.2 Global Aptamer-Drug Conjugates (ApDC) Concentration Ratio (CR)
4.2.1 Aptamer-Drug Conjugates (ApDC) Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Aptamer-Drug Conjugates (ApDC) in 2023
4.2.3 Global Aptamer-Drug Conjugates (ApDC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Aptamer-Drug Conjugates (ApDC) Head office and Area Served
4.4 Global Key Players of Aptamer-Drug Conjugates (ApDC), Product and Application
4.5 Global Key Players of Aptamer-Drug Conjugates (ApDC), Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Aptamer-Drug Conjugates (ApDC) Market Size by Company
4.7.1 Key Players of Aptamer-Drug Conjugates (ApDC) in United States, Ranked by Revenue (2023)
4.7.2 United States Aptamer-Drug Conjugates (ApDC) Revenue by Players (2022, 2023 & 2024)
5 Global Aptamer-Drug Conjugates (ApDC) Market Size by Region
5.1 Global Aptamer-Drug Conjugates (ApDC) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Aptamer-Drug Conjugates (ApDC) Market Size by Region (2019-2030)
5.2.1 Global Aptamer-Drug Conjugates (ApDC) Market Size by Region: 2019-2024
5.2.2 Global Aptamer-Drug Conjugates (ApDC) Market Size by Region: 2025-2030
6 Americas
6.1 Americas Aptamer-Drug Conjugates (ApDC) Market Size YoY Growth 2019-2030
6.2 Americas Aptamer-Drug Conjugates (ApDC) Market Size by Type
6.2.1 Americas Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024)
6.2.2 Americas Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030)
6.2.3 Americas Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
6.3 Americas Aptamer-Drug Conjugates (ApDC) Market Size by Application
6.3.1 Americas Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024)
6.3.2 Americas Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030)
6.3.3 Americas Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
6.4 Americas Aptamer-Drug Conjugates (ApDC) Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Aptamer-Drug Conjugates (ApDC) Market Size YoY Growth 2019-2030
7.2 EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Type
7.2.1 EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024)
7.2.2 EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030)
7.2.3 EMEA Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
7.3 EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Application
7.3.1 EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024)
7.3.2 EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030)
7.3.3 EMEA Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
7.4 EMEA Aptamer-Drug Conjugates (ApDC) Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Aptamer-Drug Conjugates (ApDC) Market Size by Type
8.1.1 China Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024)
8.1.2 China Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030)
8.1.3 China Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
8.2 China Aptamer-Drug Conjugates (ApDC) Market Size by Application
8.2.1 China Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024)
8.2.2 China Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030)
8.2.3 China Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Aptamer-Drug Conjugates (ApDC) Market Size YoY Growth 2019-2030
9.2 APAC Aptamer-Drug Conjugates (ApDC) Market Size by Type
9.2.1 APAC Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024)
9.2.2 APAC Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030)
9.2.3 APAC Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
9.3 APAC Aptamer-Drug Conjugates (ApDC) Market Size by Application
9.3.1 APAC Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024)
9.3.2 APAC Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030)
9.3.3 APAC Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
9.4 APAC Aptamer-Drug Conjugates (ApDC) Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 Aptamer Sciences
10.1.1 Aptamer Sciences Company Details
10.1.2 Aptamer Sciences Business Overview
10.1.3 Aptamer Sciences Aptamer-Drug Conjugates (ApDC) Introduction
10.1.4 Aptamer Sciences Revenue in Aptamer-Drug Conjugates (ApDC) Business (2019-2024)
10.1.5 Aptamer Sciences Recent Development
10.2 Oligon
10.2.1 Oligon Company Details
10.2.2 Oligon Business Overview
10.2.3 Oligon Aptamer-Drug Conjugates (ApDC) Introduction
10.2.4 Oligon Revenue in Aptamer-Drug Conjugates (ApDC) Business (2019-2024)
10.2.5 Oligon Recent Development
10.3 AptaBio Therapeutics
10.3.1 AptaBio Therapeutics Company Details
10.3.2 AptaBio Therapeutics Business Overview
10.3.3 AptaBio Therapeutics Aptamer-Drug Conjugates (ApDC) Introduction
10.3.4 AptaBio Therapeutics Revenue in Aptamer-Drug Conjugates (ApDC) Business (2019-2024)
10.3.5 AptaBio Therapeutics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Aptamer-Drug Conjugates (ApDC) Market Size, United States VS Global, CAGR (2019 VS 2023 VS 2030)
Table 2. Aptamer-Drug Conjugates (ApDC) Market Trends
Table 3. Aptamer-Drug Conjugates (ApDC) Market Drivers
Table 4. Aptamer-Drug Conjugates (ApDC) Market Challenges
Table 5. Aptamer-Drug Conjugates (ApDC) Market Restraints
Table 6. Global Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. United States Aptamer-Drug Conjugates (ApDC) Market Size by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. United States Aptamer-Drug Conjugates (ApDC) Market Size by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Key Companies of Aptamer-Drug Conjugates (ApDC), Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Aptamer-Drug Conjugates (ApDC) Revenue by Player, (US$ Million), 2019-2024
Table 12. Global Aptamer-Drug Conjugates (ApDC) Revenue Share by Player, 2019-2024
Table 13. Global Aptamer-Drug Conjugates (ApDC) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aptamer-Drug Conjugates (ApDC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aptamer-Drug Conjugates (ApDC) as of 2023)
Table 15. Global Key Players of Aptamer-Drug Conjugates (ApDC), Headquarters and Area Served
Table 16. Global Key Players of Aptamer-Drug Conjugates (ApDC), Product and Application
Table 17. Global Key Players of Aptamer-Drug Conjugates (ApDC), Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Aptamer-Drug Conjugates (ApDC) in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Aptamer-Drug Conjugates (ApDC) Revenue by Players, (US$ Million), 2022, 2023 & 2024
Table 21. United States Aptamer-Drug Conjugates (ApDC) Revenue Share by Players, 2022, 2023 & 2024
Table 22. Global Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 23. Global Aptamer-Drug Conjugates (ApDC) Market Size by Region (2019-2024) & (US$ Million)
Table 24. Global Aptamer-Drug Conjugates (ApDC) Market Size Forecast by Region (2025-2030) & (US$ Million)
Table 25. Americas Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024) & (US$ Million)
Table 26. Americas Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030) & (US$ Million)
Table 27. Americas Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Americas Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030) & (US$ Million)
Table 29. Americas Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 30. Americas Aptamer-Drug Conjugates (ApDC) Market Size by Country (2019-2024) & (US$ Million)
Table 31. Americas Aptamer-Drug Conjugates (ApDC) Market Size by Country (2025-2030) & (US$ Million)
Table 32. EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024) & (US$ Million)
Table 33. EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030) & (US$ Million)
Table 34. EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024) & (US$ Million)
Table 35. EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030) & (US$ Million)
Table 36. EMEA Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 37. EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Region (2019-2024) & (US$ Million)
Table 38. EMEA Aptamer-Drug Conjugates (ApDC) Market Size by Region (2025-2030) & (US$ Million)
Table 39. China Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024) & (US$ Million)
Table 40. China Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030) & (US$ Million)
Table 41. China Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024) & (US$ Million)
Table 42. China Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030) & (US$ Million)
Table 43. APAC Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2024) & (US$ Million)
Table 44. APAC Aptamer-Drug Conjugates (ApDC) Market Size by Type (2025-2030) & (US$ Million)
Table 45. APAC Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2024) & (US$ Million)
Table 46. APAC Aptamer-Drug Conjugates (ApDC) Market Size by Application (2025-2030) & (US$ Million)
Table 47. APAC Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 48. APAC Aptamer-Drug Conjugates (ApDC) Market Size by Region (2025-2030) & (US$ Million)
Table 49. APAC Aptamer-Drug Conjugates (ApDC) Market Size by Region (2025-2030) & (US$ Million)
Table 50. Aptamer Sciences Company Details
Table 51. Aptamer Sciences Business Overview
Table 52. Aptamer Sciences Aptamer-Drug Conjugates (ApDC) Product
Table 53. Aptamer Sciences Revenue in Aptamer-Drug Conjugates (ApDC) Business (2019-2024) & (US$ Million)
Table 54. Aptamer Sciences Recent Development
Table 55. Oligon Company Details
Table 56. Oligon Business Overview
Table 57. Oligon Aptamer-Drug Conjugates (ApDC) Product
Table 58. Oligon Revenue in Aptamer-Drug Conjugates (ApDC) Business (2019-2024) & (US$ Million)
Table 59. Oligon Recent Development
Table 60. AptaBio Therapeutics Company Details
Table 61. AptaBio Therapeutics Business Overview
Table 62. AptaBio Therapeutics Aptamer-Drug Conjugates (ApDC) Product
Table 63. AptaBio Therapeutics Revenue in Aptamer-Drug Conjugates (ApDC) Business (2019-2024) & (US$ Million)
Table 64. AptaBio Therapeutics Recent Development
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
List of Figures
Figure 1. Aptamer-Drug Conjugates (ApDC) Product Picture
Figure 2. Global Aptamer-Drug Conjugates (ApDC) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Aptamer-Drug Conjugates (ApDC) Market Size 2019-2030 (US$ Million)
Figure 4. United States Aptamer-Drug Conjugates (ApDC) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 5. United States Aptamer-Drug Conjugates (ApDC) Market Size 2019-2030 (US$ Million)
Figure 6. United States Aptamer-Drug Conjugates (ApDC) Market Share in Global 2019-2030
Figure 7. Aptamer-Drug Conjugates (ApDC) Report Years Considered
Figure 8. Product Picture of Covalent Coupling
Figure 9. Product Picture of Non-Covalent Coupling
Figure 10. Global Aptamer-Drug Conjugates (ApDC) Market Share by Type in 2023 & 2030
Figure 11. Global Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2030) & (US$ Million)
Figure 12. Global Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
Figure 13. United States Aptamer-Drug Conjugates (ApDC) Market Share by Type in 2023 & 2030
Figure 14. United States Aptamer-Drug Conjugates (ApDC) Market Size by Type (2019-2030) & (US$ Million)
Figure 15. United States Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
Figure 16. Product Picture of Biopharmaceutical Company
Figure 17. Product Picture of Research Institute
Figure 18. Product Picture of Other
Figure 19. Global Aptamer-Drug Conjugates (ApDC) Market Share by Application in 2023 & 2030
Figure 20. Global Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2030) & (US$ Million)
Figure 21. Global Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
Figure 22. United States Aptamer-Drug Conjugates (ApDC) Market Share by Application in 2023 & 2030
Figure 23. United States Aptamer-Drug Conjugates (ApDC) Market Size by Application (2019-2030) & (US$ Million)
Figure 24. United States Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
Figure 25. The Top 5 and 10 Largest Companies of Aptamer-Drug Conjugates (ApDC) in the World: Market Share by Aptamer-Drug Conjugates (ApDC) Revenue in 2023
Figure 26. Global Aptamer-Drug Conjugates (ApDC) Market Size Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global Aptamer-Drug Conjugates (ApDC) Market Share by Region (2019-2030)
Figure 28. Americas Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate 2019-2030 (US$ Million)
Figure 29. Americas Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
Figure 30. Americas Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
Figure 31. United States Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 33. Mexico Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 34. Brazil Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 35. EMEA Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate 2019-2030 (US$ Million)
Figure 36. EMEA Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
Figure 37. EMEA Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
Figure 38. Europe Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 39. Middle East Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 40. Africa Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate 2019-2030 (US$ Million)
Figure 42. China Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
Figure 43. China Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
Figure 44. APAC Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate 2019-2030 (US$ Million)
Figure 45. APAC Aptamer-Drug Conjugates (ApDC) Market Share by Type (2019-2030)
Figure 46. APAC Aptamer-Drug Conjugates (ApDC) Market Share by Application (2019-2030)
Figure 47. Japan Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 48. South Korea Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 49. China Taiwan Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 50. ASEAN Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 51. India Aptamer-Drug Conjugates (ApDC) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 52. Aptamer Sciences Revenue Growth Rate in Aptamer-Drug Conjugates (ApDC) Business (2019-2024)
Figure 53. Oligon Revenue Growth Rate in Aptamer-Drug Conjugates (ApDC) Business (2019-2024)
Figure 54. AptaBio Therapeutics Revenue Growth Rate in Aptamer-Drug Conjugates (ApDC) Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Description
The global Aptamer-Drug Conjugates (ApDC) revenue was US$ 10.4 million in 2023 and is forecast to a readjusted size of US$ 24.3 million by 2030 with a CAGR of 13.1% during the review period (2024-2030). In United States the Aptamer-Drug Conjugates (ApDC) revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Aptamer-Drug Conjugates (ApDC) market, also covers the segmentation data of other regions in regional level and county level.
Aptamer-drug conjugates (ApDC) is a new form of drug that combines the specificity of nucleic acid aptamers and the therapeutic effect of drug molecules. ApDC connects nucleic acid aptamers and drug molecules through chemical linkers to form a complex with targeting and therapeutic effects.
The global key players of Aptamer-Drug Conjugates (ApDC) include Aptamer Sciences, Oligon, AptaBio Therapeutics, etc. The global five biggest players hold a share of % in 2023.
Global Aptamer-Drug Conjugates (ApDC) Scope and Market Size
Aptamer-Drug Conjugates (ApDC) market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Aptamer-Drug Conjugates (ApDC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Aptamer-Drug Conjugates (ApDC) market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
Market Segmentation
Chapter Outline
Chapter 1: Introduces Aptamer-Drug Conjugates (ApDC) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Aptamer-Drug Conjugates (ApDC) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Aptamer-Drug Conjugates (ApDC) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aptamer-Drug Conjugates (ApDC) revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now